Hunan Tigermed Xiangya Drug Research and Development

Hunan Tigermed Xiangya Drug Research and Development is a specialized Contract Research Organization (CRO) based in Changsha, China, that focuses on early-phase clinical development. A subsidiary of Hangzhou Tigermed Consulting, the company was established in collaboration with clinical pharmacology experts from the prestigious Xiangya Hospital of Central South University. It primarily provides services for Phase I clinical trials, bioequivalence (BE) studies, and clinical pharmacokinetic research. The organization operates a dedicated Phase I clinical ward and a bioanalytical laboratory equipped with advanced LC-MS/MS technology. By integrating academic expertise with commercial CRO efficiency, it supports pharmaceutical companies in accelerating their drug development timelines within the Chinese regulatory framework.